Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1996
12/17/1996US5585484 Using ethoxylated phenylmaleimido compounds
12/17/1996US5585468 Substituted thioureas as bifunctional chelators
12/17/1996US5585457 Branching, three-dimensional morphology; radio-imaging, drugdelivery, catalyst, chromatography calibration
12/17/1996US5585406 Nonirritating nonionic tissue cleaning method
12/17/1996US5585379 Skin disorders
12/17/1996US5585115 Agglomerated particles comprising microcrystalline cellulose and silicon oxide; tensile strength
12/17/1996US5585114 Active substance incorporated in matrix material of polysaccharide comprising crystalline straight chain alpha-glucan having helix structure
12/17/1996US5585112 Method of preparing gas and gaseous precursor-filled microspheres
12/17/1996US5585111 Transdermal delivery device
12/17/1996US5585108 Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays
12/17/1996US5585100 Vaccine; diagnosis, therapy and prevention of disease
12/17/1996CA2062137C Method for anesthesia
12/17/1996CA2013772C N-(sulfomethyl)-n'-arylureas
12/14/1996CA2178691A1 Oral formulations of s(+)-ibuprofen
12/14/1996CA2178686A1 Oral formulations of s(+)-etodolac
12/13/1996CA2178789A1 Hemostyptic and tissue adhesive
12/12/1996WO1996039222A1 Device for transdermal electrotransport delivery of fentanyl and sufentanil
12/12/1996WO1996039202A1 Biocompatible hydroxyapatite formulations and uses therefor
12/12/1996WO1996039197A1 Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound
12/12/1996WO1996039193A2 Drug mitochondrial targeting agents
12/12/1996WO1996039192A1 Treatment of cholera
12/12/1996WO1996039191A1 Treatment of cholera
12/12/1996WO1996039190A1 Treatment of traveller's diarrhea
12/12/1996WO1996039189A1 Treatment of traveller's diarrhea
12/12/1996WO1996039183A1 Compositions and methods for targeted delivery of effector molecules
12/12/1996WO1996039180A1 Immunogen preparation with hapten
12/12/1996WO1996039169A1 Methods and compositions for healing and repair of connective tissue attachment
12/12/1996WO1996039164A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
12/12/1996WO1996039160A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides
12/12/1996WO1996039159A1 Collagen-based delivery matrix
12/12/1996WO1996039156A2 Phosphate-binding polymers for oral administration
12/12/1996WO1996039152A1 Use of locally applied dna fragments
12/12/1996WO1996039146A1 Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
12/12/1996WO1996039143A1 Pharmaceutical formulations of highly lipophilic camptothecin derivatives
12/12/1996WO1996039142A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
12/12/1996WO1996039139A1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
12/12/1996WO1996039134A1 Osteogenetic promoting pharmaceutical composition
12/12/1996WO1996039131A1 Topical composition for fungal treatment
12/12/1996WO1996039128A1 Protein particles for therapeutic and diagnostic use
12/12/1996WO1996039124A1 Polymer affinity systems for the delivery of cytotoxic materials and other compounds to sites of disease
12/12/1996WO1996039122A1 POLY-β-1→4-N-ACETYLGLUCOSAMINE
12/12/1996WO1996039119A1 Topical vehicles containing solubilized and stabilized azelaic acid
12/12/1996WO1996039095A1 Ocular inserts
12/12/1996WO1996039029A1 Methods of making sustained release biocidal compositions
12/12/1996WO1996030028A3 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
12/12/1996WO1996022110A3 Pharmaceutical products containing thermally-inhibited starches
12/12/1996DE19622902A1 Zusammensetzung zur Steigerung der Permeation der Haut, welche Glycerinmonolaurat und Laurylacetat umfassen Comprise composition for enhancing the permeation of the skin which glycerol monolaurate and lauryl acetate
12/12/1996DE19520743A1 Oligo-galacturonate and poly-galacturonate mixed complexes
12/12/1996DE19520659A1 Compsn. to treat virus infections of skin etc
12/12/1996CA2223596A1 Biocompatible hydroxyapatite formulations and uses therefor
12/12/1996CA2223383A1 Topical vehicles containing solubilized and stabilized azelaic acid
12/12/1996CA2223108A1 Topical composition for fungal treatment
12/12/1996CA2221784A1 Osteogenetic promoting pharmaceutical composition
12/12/1996CA2220895A1 Protein particles for therapeutic and diagnostic use
12/12/1996CA2219528A1 Stabilized compositions of fluorinated amphiphiles as contrast agents for ultrasound
12/12/1996CA2210291A1 Treatment of cholera
12/12/1996CA2210227A1 Treatment of cholera
12/12/1996CA2210202A1 Treatment of traveller's diarrhea
12/12/1996CA2210193A1 Treatment of traveller's diarrhea
12/12/1996CA2196782A1 Methods of making sustained release biocidal compositions
12/11/1996EP0747066A2 Biocompatible adhesive compositions
12/11/1996EP0747063A2 Neisseria meningitidis capsular polysaccharide conjugates
12/11/1996EP0747062A2 Stable complexes of crosslinked polyvinylpyrrolidone and iodine and method of making the same
12/11/1996EP0747061A2 Controlled release inclusion system of glycolic acid in beta-cyclo-dextrin and process for the above system preparation
12/11/1996EP0747050A1 Pharmaceutical compositions containing irbesartan
12/11/1996EP0747038A2 Thickened and stabilized cosmetic sunscreen emulsions
12/11/1996EP0746605A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity
12/11/1996EP0746342A1 Biodegradable controlled release melt-spun delivery system
12/11/1996EP0746336A1 Prodrugs activated by targeted catalytic proteins
12/11/1996EP0746334A1 Pharmaceutical preparation containing plasminogen activators
12/11/1996EP0746327A1 Acidified nitrite as an antimicrobial agent
12/11/1996EP0746326A1 Oligomeric compounds having nitrogen-containing linkages
12/11/1996EP0746317A1 Sublingual or buccal pharmaceutical composition
12/11/1996EP0746310A1 Controlled release composition
12/11/1996EP0746307A1 Cosmetic compositions
12/11/1996EP0746294A1 Absorption enhancers for topical pharmaceutical formulations
12/11/1996EP0746292A1 Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
12/11/1996EP0624171B1 Thermoplastic elastomers
12/11/1996EP0510086B1 Interdigitation-fusion liposomes and gels
12/11/1996CN1137757A Compositions and methods for stimulating megakaryocyte growth and differentiation
12/11/1996CN1137756A Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
12/11/1996CN1137564A Stable transglutaminase preparations and processes for producing them
12/11/1996CN1137406A Yunan Baiyao (White Drug-Powder) tablet and preparation method thereof
12/10/1996US5583242 Use of phosphotyrosine phosphatase inhibitors for controlling cellular proliferation
12/10/1996US5583220 Pyrole nitrogen-substituted texaphyrins
12/10/1996US5583219 Macrocyclic chelating agent
12/10/1996US5583156 An oxycarboxylic compound
12/10/1996US5583153 Administering taxol solubilized in carrier to suppress symptoms of progressive inflammatory autoimmune arthritis in mammals
12/10/1996US5583136 Retinoid containing skin care compositions containing imidazoles
12/10/1996US5583105 Oral pharmaceutical preparation
12/10/1996US5583056 Forming aqueous suspension of particles of non-polymeric nuclei each surrounded by hydrophilic copolymer shell having covalent binding functional groups by polymerizing aqueous mixture of monomers in colloidal dispersion of particles
12/10/1996US5582815 Device for dispensing a therapeutic or cosmetic substance, the inert vehicle of which is a volatile polydiorganosiloxane, and composition intended to be used in the device
12/10/1996US5582591 Delivery of solid drug compositions
12/10/1996US5582172 Intravascular administering a particle carrier comprising an organic inner core surface grafted with carbohydrates specific bonding to lymph nodes
12/10/1996CA2060507C Factor xa based anticoagulant compositions
12/10/1996CA2017285C Stabilized calcitonin pharmaceutical composition
12/10/1996CA2016659C Stabilized compositions containing epidermal growth factor
12/10/1996CA1338781C Ligands and methods for augmenting b-cell proliferation
12/10/1996CA1338779C Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
12/10/1996CA1338777C Methods and compositions for preventing secondary cataracts
1 ... 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 ... 1712